Cargando...
Novel Preclinical and Radiopharmaceutical Aspects of [(68)Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
The detection of prostate cancer lesions by PET imaging of the prostate-specific membrane antigen (PSMA) has gained highest clinical impact during the last years. (68)Ga-labelled Glu-urea-Lys(Ahx)-HBED-CC ([(68)Ga]Ga-PSMA-HBED-CC) represents a successful novel PSMA inhibitor radiotracer which has re...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2014
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4113732/ https://ncbi.nlm.nih.gov/pubmed/24983957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph7070779 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|